Expert Consortium Launches Chemistry
Playbook®, Expedited CMC Solutions From
Cambridge Major Laboratories, Xcelience,
Beckloff Associates, and Avantium Pharma
Chemistry Playbook® Is a Series of Proven, Modular, Expedited CMC Solutions Designed to Accelerate Drug
Development from Carbon to Commercialization
March 09, 2010 08:03 AM Eastern Time
TAMPA, Fla.--(EON: Enhanced Online News)--Cambridge Major Laboratories, Inc., Avantium Pharma,
Xcelience, LLC and Beckloff Associates have formed a consortium of expert client-focused companies to launch
Chemistry Playbook®, an expedited CMC solutions program designed to accelerate drug development.
Cambridge Major Laboratories Chief Business Officer Brian Scanlan says, “Chemistry Playbook® accelerates drug
development from carbon to commercialization by delivering where other competitive, expedited programs fall
short:program execution.We came together as experts in our respective areas to build a modular program that could
achieve the true goal of expedited CMC solutions.”
Xcelience CEO & President Derek Hennecke adds, “Fixed timelines and price are easy to guarantee under ideal
conditions (simple API synthesis, straightforward physical properties, or easy-to-formulate products), but in reality
these are rare cases.Recognizing that each drug development candidate is unique, we fit the process to the situation,
not the other way around.We started with the client needs and went from there.”
Quality can vary across functional business units within larger service providers, but Chemistry Playbook’s
consortium model guarantees functional expertise and accountability at every stage.
l Play Execution - From Gantt charts to handoffs, for individuals or the entire team; we’ve designed the plays
to fit the situation.
l Bench Strength - Access Beckloff Associates for CMC / regulatory oversight, Cambridge Major
Laboratories for API, Avantium Pharma for solid state characterization, and Xcelience for formulation
development expertise.
l Four Stops, One